IMV

-$0.03 (-1.85%) Today
$0.00 (0.00%) As of 9:06 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMV and other ETFs, options, and stocks.

About IMV

IMV, Inc. is a clinical-stage biopharmaceutical company that engages in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. The company leverages its delivery platform (DPX) that programs immune cells directly within the human body to produce robust and sustained target killing capabilities.

CEO
Andrew Hall
Employees
—
Headquarters
Dartmouth, Nova Scotia
Founded
2007

IMV Key Statistics

Market Cap
131.07M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
224.94K
High Today
$1.63
Low Today
$1.57
Open Price
$1.62
Volume
210.81K
52 Week High
$4.60
52 Week Low
$1.31

IMV Earnings

-$0.19
-$0.13
-$0.06
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure